Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause.

Maturitas - 30 Nov 2001

Tolosa M, Peiró S, Real J T, Cano A, Ascaso J F, Carmena R

Abstract excerpt

OBJECTIVE: To study the influence of apo E phenotype in plasma lipids, especially in triglycerides levels, in menopausal women receiving hormonal replacement therapy (HRT). METHODS: One hundred and ten postmenopausal women were studied. Plasma total cholesterol (TC), HDL-C and triglycerides (TG) were measured before and after 3 months of HRT and the apo E phenotype was determined. According to the apo E phenotype...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Cutaneous
Share to Administration, Oral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cholesterol

Share to Cholesterol, HDL

Share to Estradiol

Share to Hormone Replacement Therapy

Share to Menopause

Share to Triglycerides

Source

Identifiers

PMID: 11716996
DOI: 10.1016/s0378-5122(01)00237-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause.PMID 11716996Read ↗

Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy.Semantic proximity Read ↗

Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy.Semantic proximity Read ↗

Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene.Semantic proximity Read ↗

The association between hypertriglyceridemic waist phenotype, menopause, and cardiovascular risk factors.Semantic proximity Read ↗

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?Semantic proximity Read ↗

Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?Semantic proximity Read ↗

Apolipoprotein E genotype and response of lipid levels to postmenopausal estrogen use.Semantic proximity Read ↗

ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.Semantic proximity Read ↗

Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.Semantic proximity Read ↗

Relation between apolipoprotein e phenotype and the changes in lipids during tamoxifen treatment.Semantic proximity Read ↗

Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women.Semantic proximity Read ↗

Apolipoprotein E gene determines serum testosterone and dehydroepiandrosterone levels in postmenopausal women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.